Evolution of the Average Target: Sight Sciences, Inc.

Evolution of the Average Target - Sight Sciences, Inc.

Evolution of the Target Price: Sight Sciences, Inc.

Evolution of the Target Price - Sight Sciences, Inc.

Changes in Analyst Recommendations: Sight Sciences, Inc.

55901e8ec776c60bbaabd53970.OWNlKtcBVjaP8O-PjpmOSvaBzfKO4GV-HzRn-whfaOE.CgAQRpBeGnfCo6vH76_8OoPvp7_BuFRJRkIRvEdsOKtbThxmklZlA7ujnA~5dd37fcd3fbcc8a4d29dcb486cb929d6
10-15 HC Wainwright Initiates Coverage on Sight Sciences With Buy Rating, $14 Price Target MT
08-06 UBS Adjusts Price Target on Sight Sciences to $8 From $7, Maintains Buy Rating MT
07-28 UBS Adjusts Price Target on Sight Sciences to $7 From $11, Maintains Buy Rating MT
01-05 Sight Sciences Shares Rise After Piper Sandler Upgrade MT
01-05 Piper Sandler Upgrades Sight Sciences to Overweight From Neutral, Adjusts Price Target to $9 From $5 MT
25-01-27 UBS Adjusts Price Target on Sight Sciences to $5 From $5.50, Keeps Buy Rating MT
24-12-06 UBS Initiates Sight Sciences at Buy With $5.50 Price Target MT
24-11-04 Lake Street Downgrades Sight Sciences to Hold From Buy, Price Target is $5 MT
24-08-21 Lake Street Initiates Coverage on Sight Sciences With Buy Rating, $10 Price Target MT
24-07-15 Morgan Stanley Raises Price Target on Sight Sciences to $6.50 From $5.40, Keeps Equalweight Rating MT
24-03-08 Stifel Adjusts Price Target on Sight Sciences to $7 From $6, Keeps Buy Rating MT
23-12-04 Morgan Stanley Adjusts Sight Sciences Price Target to $4 From $3, Maintains Equal Weight Rating MT
23-09-18 Stifel Adjusts Price Target on Sight Sciences to $5 From $11, Maintains Buy Rating MT
23-09-15 Citigroup Trims Price Target on Sight Sciences to $4 From $8, Maintains Neutral Rating MT
23-09-13 Morgan Stanley Trims Price Target on Sight Sciences to $4 From $8.40, Maintains Equalweight Rating MT
23-09-12 BofA Securities Downgrades Sight Sciences to Underperform From Neutral, Adjusts Price Target to $4.50 From $10 MT
23-09-12 William Blair Downgrades Sight Sciences to Market Perform From Outperform MT
23-09-12 Piper Sandler Downgrades Sight Sciences to Neutral From Overweight, Adjusts Price Target to $5.50 From $15 MT
23-08-24 Morgan Stanley Downgrades Sight Sciences to Equalweight From Overweight, Adjusts Price Target to $8.40 From $12 MT
23-08-21 Citigroup Trims Sight Sciences Price Target to $8 From $9, Maintains Neutral Rating MT
23-07-11 Citigroup Downgrades Sight Sciences to Neutral From Buy, Adjusts Price Target to $9 From $15 MT
23-07-10 Citigroup Downgrades Sight Sciences to Neutral From Buy, Lowers Price Target to $9 From $15 MT
23-06-26 Stifel Adjusts Price Target on Sight Sciences to $13 From $15, Maintains Buy Rating MT
23-06-06 BofA Securities Adjusts Sight Sciences Price Target to $10 From $13, Maintains Buy Rating MT
23-01-06 Morgan Stanley Adjusts Sight Sciences' Price Target to $15 From $11, Keeps Overweight Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+13.09%
+14.29%
+18.06%
+9.65%
+19.16%
+11.51%
+17.34%
-1.68%
+24.56%
+29.2%
Average +15.52%
Weighted average by Cap. +14.87%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
8.990USD
Average target price
10.17USD
Spread / Average Target
+13.09%
High Price Target
14.00USD
Spread / Highest target
+55.73%
Low Price Target
8.000USD
Spread / Lowest Target
-11.01%

Analyst Consensus Detail

Analyst consensus - Sight Sciences, Inc.

Consensus revision (last 18 months)

Consensus revision (last 18 months) - Sight Sciences, Inc.
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - Sight Sciences, Inc.
  1. Stock Market
  2. Stocks
  3. SGHT Stock
  4. Consensus Sight Sciences, Inc.